Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia.
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
The objective of this study was to determine the effect of delayed therapy on morbidity and mortality associated with nosocomial Staphylococcus aureus bacteremia. The study included all episodes of S. aureus bacteremia that developed >2 days after hospital admission during 1999 to 2001. Classification and regression tree analysis (CART) was used to select the mortality breakpoint between early and delayed treatment. During the 25-month study period, 167 patients met the inclusion criteria. The breakpoint between delayed and early treatment derived using CART was 44.75 hours. On multivariate analysis, delayed treatment was found to be an independent predictor of infection-related mortality (odds ratio, 3.8; 95% confidence interval, 1.3-11.0; P=.01) and was associated with a longer hospital stay than was early treatment (20.2 days versus 14.3 days; P=.05). These findings support the notion that delay of therapy has deleterious effects on clinical outcomes, and efforts should be made to ensure that appropriate therapy is initiated promptly.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among patients with documented MRSA infections, delays of > 24–48 h until antibiotic administration are associated with increased mortality in some studies [143–147], but not in others [148–154].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [145]
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Medical Entomology and Zoology · Cited by 17,248
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376 · cited 1×
“non-ICU), presence of a central venous catheter, receipt of total parenteral nutrition (TPN) or mechanical ventilation at the onset of SAB, source of bacteremia, and severity of illness at the onset of SAB (as calculated on the basis of the APACHE II score [17]).”
MethodCDC definitions for nosocomial infections, 1988
Garner, J. S., Jarvis, W. R., Emori, T. G., Horan, T. C., & Hughes, J. M. (1988) · American Journal of Infection Control · doi:10.1016/0196-6553(88)90053-3 · Cited by 5,672
CDC definitions for nosocomial infections
Yangco, B. G. (1989) · American Journal of Infection Control · doi:10.1016/s0196-6553(89)80013-6 · Cited by 3,770 · cited 1×
“Only cases of SAB that occurred 2 days after hospital admission and that met the Centers for Disease Control and Prevention (CDC) criteria for bloodstream infection were included in the analysis [15].”
MethodIbrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779 · cited 1×
“[11] reported that patients who received inappropriate empirical therapy for bloodstream infections in the ICU were at an almost 7-fold higher risk of mortality, compared with patients who received adequate antimicrobial therapy.”
Background(1995) · American Journal of Infection Control · doi:10.1016/0196-6553(95)90104-3 · Cited by 709
The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection
Leibovici, Shraga, Drucker, Konigsberger, Samra, Pitlik, & Pitlik (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00379.x · Cited by 685 · cited 1×
“4%) of 398 patients with SAB did not receive appropriate therapy 48 h after the first positive blood culture result was obtained [9].”
BackgroundBoyce, J. M., Opal, S. M., Chow, J. W., Zervos, M. J., Potter-Bynoe, G., Sherman, C. B., Romulo, R. L., Fortna, S., & Medeiros, A. A. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.5.1148-1153.1994 · Cited by 485 · cited 1×
“The widespread use of vancomycin to treat methicillinresistant Staphylococcus aureus (MRSA) infection has coincided with an increased incidence of vancomycinresistant enterococci (VRE) infections, and numerous studies have suggested an association between vancomycin use and the emergence of VRE [ 1-5].”
Background
Cited by
Items 301–400 of 650
Sullivan, S. B., Austin, E. D., Stump, S., Mathema, B., Whittier, S., Lowy, F. D., & Uhlemann, A. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00316-17 · Cited by 23
“81 Percutaneous device 24 (10) 15 (9) 9 (11) 0.”
Buonomini, A. R., Riva, E., Bonaventura, G. D., & Gherardi, G. (2020) · Diagnostics · doi:10.3390/diagnostics10100830 · Cited by 23
Community-onset healthcare-associated MRSA bacteraemia in a district general hospital
Karas, J. A., Enoch, D., & Emery, M. M. (2006) · Journal of Hospital Infection · doi:10.1016/j.jhin.2005.10.001 · Cited by 23
Balada-Llasat, J.-M., Stamas, N., Vincent, T., Timbrook, T. T., Saiontz-Martinez, C., Hemmert, R. B., & Berger, A. (2022) · Antibiotics · doi:10.3390/antibiotics11121732 · Cited by 22
Linezolid Has Unique Immunomodulatory Effects in Post-Influenza Community Acquired MRSA Pneumonia
Bhan, U., Podsiad, A. B., Kovach, M. A., Ballinger, M. N., Keshamouni, V. G., & Standiford, T. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0114574 · Cited by 22
“Development of acute lung injury in patients with post influenza MRSA infections has been identified as one potential explanation for the excess mortality observed with this organism [26].”
BackgroundChan, W.-S., Chan, T. M., Lai, T.-W., Chan, J. F., Lai, R. W. M., Lai, C. K. C., & Tang, B. S. F. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku411 · Cited by 22
Wi, Y. M., Rhee, J.-Y., Kang, C., Chung, D. R., Song, J., & Peck, K. R. (2018) · Epidemiology and Infection · doi:10.1017/s0950268818001255 · Cited by 22
Nishiguchi, S., Nishino, K., Kitagawa, I., & Tokuda, Y. (2020) · Medicine · doi:10.1097/md.0000000000021418 · Cited by 22
“On the other hand, delay in diagnosis and initiation of therapy lead to complications and unfavorable outcomes.([11]) Therefore, delayed diagnosis of IE is a critical issue that needs to be resolved, to save lives and avoid disability.”
BackgroundWeber, S. G., Miller, R. R., Perencevich, E. N., Tolentino, J., Meltzer, D., PITRAK, D. L., McGregor, J. C., Sachs, G. A., Harris, A. D., & Furuno, J. P. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp349 · Cited by 22
“A higher frequency of antimicrobial resistance among older patients could increase the likelihood of delay in the initiation of antimicrobial agents to which the causative pathogen is susceptible, further increasing the risk of subsequent morbidity and mortality for these patients.(8,9) Much of the evidence suggesting…”
BackgroundEllem, J. A., Olma, T., & O'Sullivan, M. V. N. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.02155-15 · Cited by 22
Prevention and Treatment of Health Care–Acquired Infections
Gasink, L. B., & Lautenbach, E. (2008) · Medical Clinics of North America · doi:10.1016/j.mcna.2007.10.002 · Cited by 22
Zasowski, E. J., Trinh, T. D., Atwan, S. M., Merzlyakova, M., Langf, A. M., Bhatia, S., & Rybak, M. J. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz079 · Cited by 21
Self-citationRetractedEffects of Delayed Antibiotic Therapy on Outcomes in Children with Streptococcus pneumoniae Sepsis
Li, Q., Cheng, J., Wu, Y., Wang, Z., Luo, S., Li, Y., Tian, X., Zhang, G., Chen, D., & Luo, Z. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00623-19 · Cited by 21
“75 h for Staphylococcus aureus bacteremia (7) and 52 h for Pseudomonas aeruginosa bacteremia (8).”
BackgroundHernandez, B., Ming, D. K. Y., Rawson, T. M., Bolton, W., Wilson, R. C., Vasikasin, V., Daniels, J., Rodríguez-Manzano, J., Davies, F., Georgiou, P., et al. (2024) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2024.103008 · Cited by 21
Importance of vancomycin loading doses in intermittent infusion regimens
Šíma, M., Hartinger, J. M., Cikánková, T., & Slanař, O. (2017) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2017.11.002 · Cited by 21
Sullivan, K. V., Turner, N. N., Roundtree, S. S., & McGowan, K. L. (2013) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2012-0422-oa · Cited by 21
Risk factors for mortality caused by Staphylococcus aureus bacteremia in cancer patients
Cuervo, S. I., Cortés, J. A., Sánchez, R., Rodríguez, J. Y., Silva, E., Tibavizco, D., & Arroyo, P. (2010) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2009.06.015 · Cited by 21
An after-hours clinical liaison blood culture service—is it worth it?
Fitzpatrick, F., Turley, M., Humphreys, H., & Smyth, E. G. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.00914.x · Cited by 21
Adherence to Guidelines on Empiric Use of Antibiotics in the Emergency Room
Galayduyk, N., Colodner, R., Chazan, B., FLATAU, E., Lavi, I., & Raz, R. (2008) · Infection · doi:10.1007/s15010-008-6306-1 · Cited by 21
“For example, Lodise et al. [ 24 ] and Khatib et al. [25] demonstrated that the delay of appropriate therapy for Staphylococcus aureus bacteremia was associated with a higher mortality rate, although Kim et al. [26], did not.”
BackgroundOverview of tigecycline and its role in the era of antibiotic resistance
Rossi, F., & Andreazzi, D. (2006) · The Brazilian Journal of Infectious Diseases · doi:10.1590/s1413-86702006000300010 · Cited by 21
“05) [9].”
Thuny, F., Laas, O., Saby, L., Tessonnier, L., Cammilleri, S., Casalta, J., MUNDLER, O., Raoult, D., & Habib, G. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.09.034 · Cited by 21
Kim, J., Joo, E., Ha, Y. E., Park, S. Y., Kang, C., Chung, D. R., Song, J., & Peck, K. R. (2013) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-1829-5 · Cited by 20
Martirosov, D. M., Bidell, M. R., Pai, M. P., Scheetz, M. H., Rosenkranz, S., & Lodise, T. P. (2017) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2017.03.008 · Cited by 20
“Given the time-critical nature of the first 48 hours of treatment for MRSA BSIs, (Lodise et al., 2003) vancomycin AUC exposure variables were estimated using the maximal a posteriori probability (MAP) procedure in ADAPT 5 for Hours 24–48 (AUC24–48h) (D’Argenio, Schumitzsky, and Wang, 2009; Lodise et al., 2009).”
BackgroundMethodSelf-citationHannan, K. N. A., Dela‐Pena, J., Miller, J. L., LaChance, E., Beganovic, M., Anderson, M., Rivelli, A. L., & Wieczorkiewicz, S. M. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa184 · Cited by 20
“Around-the-clock AMS review of patients with positive blood cultures may provide additional benefit, as delayed appropriate SAB treatment is associated with increased mortality [24].”
BackgroundFuture strategies for treating Staphylococcus aureus bloodstream infections
Naber, C. K. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.01924.x · Cited by 20
“3%) MSSA patients [35].”
BackgroundInfluentialLiaquat, S., Baccaglini, L., Haynatzki, G. R., Medcalf, S. J., & Rupp, M. E. (2020) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2020.1337 · Cited by 19
Alosaimy, S., Lagnf, A. M., Hobbs, A. L. V., Mubarez, M., Kufel, W. D., Morrisette, T., Polisetty, R. S., Li, D., Veve, M. P., Simon, S. P., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac670 · Cited by 19
Self-citationGómez-Mejía, A., Arnold, K., Bär, J., Singh, K. D., Scheier, T., Brugger, S. D., Zinkernagel, A. S., & Sinues, P. (2022) · iScience · doi:10.1016/j.isci.2022.105080 · Cited by 19
“A prompt and accurate identification of the causative pathogens of a bacterial infection is essen57 tial for providing patients with adequate treatments to reduce mortality and to prevent antibiotic 58 resistance (1-4).”
BackgroundRobinson, J. O., Phillips, M. R., Christiansen, K., Pearson, J. C., Coombs, G. W., & Murray, R. J. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12388 · Cited by 19
“aureus bacteraemia-attributable mortality was increased when active therapy was delayed beyond 45 h after the blood culture was taken [5].”
BackgroundIs reduced vancomycin susceptibility a factor associated with poor prognosis in MSSA bacteraemia?
López-Cortés, L. E., Velasco, C., Retamar, P., del Toro, M. D., Gálvez-Acebal, J., de Cueto, M., García, I., Caballero, F. J., Pascual, Á., & Rodríguez‐Baño, J. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv133 · Cited by 19
Kung, C., Hsiao, S.-Y., Su, C.-M., Tsai, T.-C., Cheng, H.-H., Tsai, N., Chang, W., Huang, C.-R., Wang, H., Lin, W.-C., et al. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.02.023 · Cited by 19
Wong, D., Wong, T., Romney, M. G., & Leung, V. C. M. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1564-5 · Cited by 19
“β-lactam monotherapy may be inadequate empiric treatment if the strain is methicillin-resistant, but mortality outcomes from retrospective studies are mixed [3, 6, 8, 25].”
BackgroundEnfoque terapéutico de la bacteriemia por Staphylococcus aureus
Tibavizco, D., Rodríguez, J. Y., Silva, E., Cuervo, S. I., & Cortés, J. A. (2007) · Biomédica · doi:10.7705/biomedica.v27i2.226 · Cited by 19
Stevenson, K., Barbera, J., Moore, J. W., Samore, M. H., & Houck, P. M. (2005) · American Journal of Medical Quality · doi:10.1177/1062860605281175 · Cited by 19
“Conversely, failure to initiate early and appropriate antimicrobial therapy can result in poor clinical outcomes in patients with significant infections.(9,10) As a significant advance in antimicrobial management, computer-based CDSS have been demonstrated to have a positive impact on prescribing, clinical outcomes, a…”
BackgroundChattaweelarp, T., Changpradub, D., Punyawudho, B., Thunyaharn, S., & Santimaleeworagun, W. (2020) · Antibiotics · doi:10.3390/antibiotics9100672 · Cited by 18
“aureus bacteremia found that delayed therapy (>45 h) was associated with with higher mortality rates and longer hospitalizations, highlighting the importance of determining the early target concentration of vancomycin [7].”
BackgroundEskesen, A. N., Belle, M. A., & Blomfeldt, A. (2018) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2018.1470666 · Cited by 18
From theory to practice: resistance in Staphylococcus aureus and new treatments
Karchmer, A. W. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01626.x · Cited by 18
Predictors of Adverse Outcomes in Children With Staphylococcus aureus Bacteremia
Kumarachandran, G., Johnson, J. K., Shirley, D.-A. T., Graffunder, E. M., & Heil, E. L. (2017) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-22.3.218 · Cited by 18
García‐Vázquez, E., Gómez, J., Madrid, R. B., Canteras, M., Ruiz, J., Baños, V., Herrero, J. A., & Valdés, M. (2007) · Medicina Clínica · doi:10.1157/13102350 · Cited by 18
Rogers, B. A., Drake, A. K., & Spelman, D. (2009) · Heart Lung and Circulation · doi:10.1016/j.hlc.2008.10.016 · Cited by 17
Evaluation of the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
Usery, J. B., Vo, N. H., Finch, C. K., Cleveland, K. O., Gelfand, M. S., & Self, T. H. (2014) · The American Journal of the Medical Sciences · doi:10.1097/maj.0000000000000338 · Cited by 17
Snydman, D. R. (2012) · Journal of Hospital Medicine · doi:10.1002/jhm.980 · Cited by 17
“In addition to inadequate initial therapy, a delay in the onset of adequate therapy has also been shown to have negative impact on outcome in patients with VAP, bacteremia, or intra-abdominal infections.(12,13,27,38,39) For example, Iregui et al.”
BackgroundSturm, P., Kwa, D., Vos, F. J., Bartels, C. J. M., & Schülin, T. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.01966.x · Cited by 17
“aureus bacteraemia, patient outcome is poorer if appropriate treatment is delayed [7,8].”
BackgroundKarau, M. J., Tilahun, M. E., Krogman, A., Osborne, B. A., Goldsby, R. A., David, C. S., Mandrekar, J. N., Patel, R., & Rajagopalan, G. (2016) · Virulence · doi:10.1080/21505594.2016.1267894 · Cited by 17
“infection and initiation of therapy.(18) During this time”
BackgroundBias, T. E., Vincent, W. R., Trustman, N., Berkowitz, L. B., & Venugopalan, V. (2017) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp160096 · Cited by 17
Reevaluation of the periodic acid-Schiff stain in acute leukemia with immunophenotypic analyses.
Snower, D. P., Smith, B. R., Munz, U. J., & McPhedran, P. (1991) · PubMed · Cited by 17
Antimicrobial therapy ofStaphylococcus aureusbloodstream infection
Tacconelli, E., & Cataldo, M. A. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.15.2505 · Cited by 17
“However, other studies showed that the length of delay between blood culture sampling and start of glycopeptides therapy did not adversely affect the outcome, after adjusting for the effect of confounding variables [20,21] .”
BackgroundMing, D. K. Y., Vasikasin, V., Rawson, T. M., Georgiou, P., Davies, F., Holmes, A. H., & Hernandez, B. (2025) · The Lancet Digital Health · doi:10.1016/j.landig.2025.01.010 · Cited by 16
Methicillin-resistant Staphylococcus aureus bacteraemia and mortality in a teaching hospital
Beeston, C., Gupta, R., Chadwick, P. R., & Young, R. J. (2008) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-008-0675-3 · Cited by 16
Sibbritt, D. W., & Gibberd, R. W. (2004) · Health Care Management Science · doi:10.1023/b:hcms.0000039379.32963.9e · Cited by 16
Lapin, J. S., Smith, R. D., Hornback, K. M., Johnson, J. K., & Claeys, K. C. (2023) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2813 · Cited by 15
Bloodstream infections: the problem and the challenge
Karchmer, A. W. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(09)70556-4 · Cited by 15
“Recognition of these patterns in BSIs is crucial to initiating effective empirical therapy, which in turn is required to minimise mortality, particularly among ICU patients [4–6].”
BackgroundClinical indices and mortality of hospitalized avian influenza A (H7N9) patients in Guangdong, China
Yang, Y., Li, X., Birkhead, G. S., Zheng, Z., & Lu, J. (2019) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000043 · Cited by 15
“Logistic regression analyses were used to control for confounding variables separately for each of the indices of interest.([25])”
MethodFaheem, S. M. (2021) · Pure and Applied Biology · doi:10.19045/bspab.2022.110037 · Cited by 15
Napolitano, L. M. (2005) · Surgical Infections · doi:10.1089/sur.2005.6.s2-5 · Cited by 15
“Furthermore, delayed treatment of MRSA bacteremia was associated with an even higher risk of death (OR, 8.3; 95% CI, 2.6-16.8) [63].”
InfluentialThe surviving sepsis guidelines: “Lost in translation”*
Landucci, D. L. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000130834.99548.d9 · Cited by 15
Antibiotic De-escalation in adults hospitalized for community-onset Sepsis
Gupta, A. B., Heath, M., Walzl, E., Ratz, D., Munroe, E., Vaughn, V. M., Horowitz, J. K., Czilok, T., Petty, L. A., Gandhi, T. N., et al. (2026) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2025.6919 · Cited by 14
A tale of 2 digital hospitals: A qualitative study of antimicrobial stewardship teams
Dort, B. A. V., Ritchie, A., Penm, J. H.-D., Gray, T. J., Ronnachit, A., & Baysari, M. T. (2024) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.16001 · Cited by 14
“5,6 AMS programs must navigate these challenges, integrating education, feedback and collaboration to achieve optimal outcomes while minimizing potential negative impacts.”
BackgroundLodise, T. P., Patel, N., Rivera, A., Tristani, L., Lazariu, V., VanDeWall, H., & McNutt, L. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00921-13 · Cited by 14
“The following data were collected: demographics, comorbidities (21), hospitalization history, antibiotic therapy, disease severity (22, 23), concomitant medications, microbiologic data, source of infection, and laboratory data.”
MethodSelf-citationContemporary genomic approaches in the diagnosis and typing of Staphylococcus aureus
Williamson, D. A., Heffernan, H., & Nimmo, G. R. (2015) · Pathology · doi:10.1097/pat.0000000000000236 · Cited by 14
“8).(18) In theory, rapid differentiation of S.”
Prescribing Habits of Vancomycin in the Emergency Department: Are We Dosing Appropriately?
Rosini, J. M., Grovola, M. R., Levine, B. J., & Jasani, N. B. (2013) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2012.11.051 · Cited by 14
Evolving rapid methicillin-resistant Staphylococcus aureus detection: Cover all the bases
Veeraraghavan, B., Bakthavatchalam, Y., & Nabarro, L. (2017) · Journal of Global Infectious Diseases · doi:10.4103/0974-777x.199997 · Cited by 14
Forestier, E., Rémy, V., Mohseni-Zadeh, M., Lesens, O., Jauhlac, B., Christmann, D., & Hansmann, Y. (2006) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2006.11.014 · Cited by 14
Diamantis, S., Rioux, C., Bonnal, C., Farfour, É., Papy, E., Andremont, A., Yéni, P., Bouvet, É., & Lucet, J. C. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1491-8 · Cited by 14
Optimal antibacterial therapy of neonates at risk of early onset sepsis
Metsvaht, T. (2010) · DSpace repository (University of Tartu) · Cited by 14
Abbott, A. N., & Fang, F. C. (2017) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2017.08.004 · Cited by 13
Pasko, C., Hicke, B. J., Dunn, J., Jaeckel, H., Nieuwlandt, D., Weed, D., Woodruff, E., Zheng, X., & JENISON, R. D. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05534-11 · Cited by 13
“Appropriate early treatment of bloodstream infections has been associated with improved outcomes in patients (12, 21, 23, 36), and clinical outcome studies have shown that reducing the time to diagnosis decreases the patient’s length of stay and rates of morbidity and mortality (2, 4, 26, 32).”
BackgroundLeikeim, R. S. M., Kesselmeier, M., Löffler, B., Rödel, J., & Höring, S. (2019) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-019-03773-y · Cited by 13
Cortés, J. A., Garzón, D., Navarrete, J. A., & Contreras, K. M. (2010) · PubMed · Cited by 13
Na, S. H., Kim, C.-J., Kim, M., Park, J. S., Song, K., Choe, P. G., Park, W. B., Bang, J. H., Kim, E. S., Park, S., et al. (2015) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2015.12.007 · Cited by 13
“Because delayed administration of optimal antibiotics is 1 of the key factors causing the high mortality of SAB (Khatib et al., 2006; Lodise et al., 2003; Paul et al., 2010; Rodriguez-Bano et al., 2009; Ruimy et al., 2008) and affecting the length of hospitalization and hospital costs (Shorr et al.”
BackgroundSteinhaus, N., Al-talib, M., Ive, P., Boyles, T., Bamford, C., Davies, M.-A., Mendelson, M., & Wasserman, S. (2018) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2018.06.004 · Cited by 12
Frymoyer, A. R., Schwenk, H. T., Brockmeyer, J. M., & Bio, L. L. (2023) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2845 · Cited by 12
Romero‐Gómez, M. P., Cendejas‐Bueno, E., García‐Rodríguez, J., & Mingorance, J. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-3086-5 · Cited by 12
Mueller, K. L., McCammon, C., Skrupky, L. P., & Fuller, B. M. (2015) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2015.01.001 · Cited by 12
Healthcare-Associated Pneumonia: Approach to Management
Labelle, A. J., & Kollef, M. H. (2011) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2011.05.003 · Cited by 12
Weber, Z., Ariano, R. E., Lagacé-Wiens, P. R. S., & Zelenitsky, S. A. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.09.007 · Cited by 12
Thermonuclease test accuracy is preserved in methicillin-resistant Staphylococcus aureus isolates
Canning, B., bin Mohamed, I. Z., Wickramasinghe, N., Swindells, J., & O’Shea, M. K. (2020) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001166 · Cited by 12
“INTROdUCTION Staphylococcus aureus can cause devastating infections and delays in disease diagnosis and management deleteriously affect patient outcomes [1].”
BackgroundForsblom, E., Tervahartiala, T. I., Ruotsalainen, E., Järvinen, A., & Sorsa, T. A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252046 · Cited by 12
“Delayed effective antimicrobial therapy is a risk factors for poor prognosis [45].”
BackgroundDiamantis, S., Rioux, C., Bonnal, C., Papy, E., Farfour, É., Andremont, A., Yéni, P., Bouvet, É., & Lucet, J. C. (2010) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2010.06.002 · Cited by 12
The impact of appropriate antibiotic prescribing on treatment evaluation parameters
Adorka, M., Mitonga, K. H., Lubbe, M. S., Serfontein, J. H. P., & Allen, K. (2013) · Journal of Public Health in Africa · doi:10.4081/jphia.2013.e2 · Cited by 11
Viertel, K., Feles, E. A., Schulte, M., Annecke, T., & Mattner, F. (2023) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2023.107005 · Cited by 11
Consensus guidelines for initial management of neutropenic fever
Douglas, A. P., Cooley, L., McMullan, B. J., Kinsella, P. M., Laundy, N., Yap, N., Bupha‐Intr, O., Alcorn, K., Bajel, A. R., Weinkove, R., et al. (2025) · Internal Medicine Journal · doi:10.1111/imj.70248 · Cited by 11
“Glycopeptides in clinically unstable patients may be supported by some, because of increased mortality and morbidity in patients with delayed effective therapy in adults 91 and the concern for penicillin-resistant Streptococci.”
Vancomycin for treatment of invasive, multi-drug resistantStaphylococcus aureusinfections
Pope, S. D., & Roecker, A. M. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.9.1245 · Cited by 11
“Among potentially responsible factors cited are inappropriate duration of therapy [180], lack of a bactericidal activity [181], delays in initiating appropriate therapy [183] and wide disparity between MBC and MIC [60,181].”
BackgroundMacVane, S. H., Bhalodi, A. A., Dare, R. K., Rosenbaum, E. R., Wolfe, K. H., Ford, B. A., İnce, D., Kinn, P., Percival, K. M., & Humphries, R. M. (2021) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkab165 · Cited by 11
Pathogenesis of Staphylococcus aureus in Humans
Lu, T., & DeLeo, F. R. (2015) · Wiley eBooks · doi:10.1002/9781118644843.ch39 · Cited by 11
Adherence to empiric antibiotic therapy guideline in a referral teaching hospital, Tehran, Iran.
Khalili, H., Elyasi, S., Hatamkhani, S., & Dashti‐Khavidaki, S. (2012) · PubMed · Cited by 11
Dai, Y., Zhu, X., Chang, W., Lu, H., Nie, Z., Wu, Y., Yao, H., Chen, Y., Xiao, Y., & Chu, X. (2024) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2024.107176 · Cited by 10
Ho, L.-C., Yu, C., You, Y., Hsieh, Y., Hou, Y., Lin, T.-C., Chen, M., Chou, C.-H., Chen, Y., Hsu, K.-C., et al. (2024) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2024.107142 · Cited by 10
Qian, Q., Eichelberger, K., & Kirby, J. E. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.02291-13 · Cited by 10
Jung, W. J., Park, J.-H., Goo, S., Chae, J., Kim, J. W., Shin, S., & Yun, H. (2020) · Clinical Therapeutics · doi:10.1016/j.clinthera.2020.10.016 · Cited by 10
Millán, A. B., Domínguez, M. Á., Borraz, C., González, M. P., Almirante, B., Cercenado, E., Padilla, B., Pujol, M., & Rodríguez‐Baño, J. (2009) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2009.07.004 · Cited by 10
Nucleic acid amplification-based microfluidic approaches for antimicrobial susceptibility testing
Trinh, T. N. D., & Lee, N. Y. (2021) · The Analyst · doi:10.1039/d1an00180a · Cited by 10
Khosrovaneh, A., Sharma, M., & Khatib, R. (2005) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540510026445 · Cited by 10
How Many Steps along the Path Is Too Far?
Drusano, G. L. (2009) · Clinical Infectious Diseases · doi:10.1086/648680 · Cited by 10
Dar, A., Abram, T. B., & Megged, O. (2024) · BMC Pediatrics · doi:10.1186/s12887-024-04793-0 · Cited by 9
“On the other hand, Lodise et al. found that delayed therapy for nosocomial Staphylococcus aureus bacteremia increased death and lengthened hospital stay [27].”
BackgroundDekmezian, M. S., Beal, S. G., Damashek, M. J., Benavides, R., & Dhiman, N. (2015) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2015.11929215 · Cited by 9
“A reduction in time to an accurate identifi cation and susceptibility results may lead to improved patient outcomes, although literature on the magnitude of such an eff ect is mixed (6, 7).”
BackgroundWesolek, J. L., McNorton, K., Delgado, G., & Giuliano, C. A. (2017) · Journal of Chemotherapy · doi:10.1080/1120009x.2017.1389807 · Cited by 9
Weng, T.-P., Lo, C.-L., Lin, W.-L., Lee, J., Li, M.-C., Ko, W., & Lee, N. (2022) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2022.07.002 · Cited by 9
Matsubara, Y., Uchiyama, H., Higashi, T., Edagawa, A., Ishii, H., Nagata, S., Hashimoto, K., Eguchi, D., Kawanaka, H., Okuyama, T., et al. (2013) · Surgery Today · doi:10.1007/s00595-013-0648-8 · Cited by 9
“The use of prophylactic antibiotics for MRSA may be justified in such patients [23–25].”
BackgroundCaracterización clínica y microbiológica de la bacteriemia por Staphylococcus aureus
Hincapié, C., Caraballo, C., Tibaduiza-García, M. F., Garcés-Rodríguez, D. D. J., Echeverri‐Toro, L. M., Ascuntar, J., León-Álvarez, A. L., & Jaimes, F. A. (2018) · Acta Médica Colombiana · doi:10.36104/amc.2018.1074 · Cited by 9
Metadata
- Authors
- Lodise, T. P., McKinnon, P. S., Swiderski, L., & Rybak, M. J.
- Affiliations
- Detroit Receiving Hospital (US)
- Eugene Applebaum College of Pharmacy and Health Sciences (US)
- Corresponding author
- McKinnon, Peggy S.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-06-01
- Volume
- 36
- Issue
- 11
- Pages
- 1418-1423
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2102463930
- Cited by
- 604
- References
- 24
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 15 · 2023: 18 · 2022: 19 · 2021: 24 · 2020: 28 · 2019: 17 · 2018: 18 · 2017: 26 · 2016: 19 · 2015: 40 · 2014: 26 · 2013: 37 · 2012: 31
- FWCI
- 15.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Keywords
- Staphylococcus aureus bacteremia, nosocomial infections, delayed antibiotic treatment, mortality, length of hospital stay, treatment timing, classification and regression trees
- MeSH terms
- Anti-Bacterial Agents, Cross Infection, Female, Humans, Male, Middle Aged, Retrospective Studies, Staphylococcal Infections, Staphylococcus aureus, Cohort Studies, Methicillin Resistance, Bacteremia, Treatment Outcome, Outcome Assessment, Health Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.